Table 2 Epidemiological, clinical and analytical characteristics of patients included in the study, grouped by type of malaria
From: Migration-associated malaria from Africa in southern Spain
MM | SMM | p value | |
|---|---|---|---|
239 (72.6%) | 90 (27.4%) | ||
Age (years) | 34 (10) | 31 (14) | ≤ 0.01 |
Time after leaving malaria-endemic areas (%) | |||
≤ 12 months | 234 (97.9%) | 82 (91.1%) | ≤ 0.01 |
> 12 months | 5 (2.1%) | 8 (8.9%) | |
Gender (%) | |||
Male | 222 (92.9%) | 77 (85.6%) | 0.04 |
Female | 17 (7.1%) | 13 (14.4%) | |
Type of traveler | |||
VFR | 219 (91.6%) | 38 (42.2%) | ≤ 0.01 |
Non-VFR | 20 (8.4%) | 52 (57.8%) | ≤ 0.01 |
Symptoms (%) | |||
Fever | 194 (81.1%) | 18 (20.0%) | ≤ 0.01 |
Diarrhea | 9 (3.8%) | 0 (0.0%) | 0.12 |
Abdominal pain | 31 (13.0%) | 18 (20.0%) | 0.11 |
Others/asymptomatic | 5 (2.1%) | 29 (32.2%) | ≤ 0.01 |
Plasmodium species (%) | |||
P. falciparum | 229 (95.8%) | 74 (82.2%) | ≤ 0.01 |
P. ovale | 4 (1.7%) | 6 (6.7%) | |
P. malariae | 1 (0.4%) | 8 (8.9%) | |
Mixed infections | 5 (2.1%) | 2 (2.2%) | |
P. falciparum + P. malariae | 1 | 2 | |
P. falciparum + P. ovale | 3 | ||
P. malariae + P. ovale | 1 | ||
Malaria chemoprophylaxis in VFR travelers (%) | |||
No | 135 (61.6%) | 21 (55.3%) | 0.67 |
Yes | 15 (6.8%) | 8 (21.0%) | |
Inadequate or suboptimal | 22 (10.0%) | 2 (5.3%) | |
Unknown | 47(21.5%) | 7 (18.4%) | |